文献速递肿瘤 PET/CT神经核医学

用于转运体成像的小分子PET示踪剂

Small Molecule PET Tracers for Transporter Imaging.
PubMed 文献 · Semin Nucl Med · 2017-07-05

本文综述了转运体作为PET示踪剂主要靶点或摄取促进因素的重要性,涵盖神经膜神经递质或囊泡转运体的高亲和力放射性配体、用放射性标记底物研究转运体功能、以及葡萄糖转运体对2-脱氧-2-[18F]FDG摄取的必要性等内容。

要点

  • 转运体可作为PET示踪剂的主要靶点,如神经膜神经递质或囊泡转运体的高亲和力放射性配体用于脑神经末梢成像。
  • 放射性标记底物可用于研究转运体功能,如3-O-[11C]甲基葡萄糖测量血脑屏障葡萄糖转运速率。
  • 部分转运体如p-糖蛋白可将小分子外排出组织,可能对抗示踪剂的有效摄取。

核心结论

  • 转运体的结构功能多样性、在人类健康与疾病中的重要性及其在治疗药物处置中的作用,提示转运体定位与功能的在体成像将持续是PET放射性药物开发的重点。
  • 转运体已与G蛋白偶联受体、配体门控离子通道、酶和聚集蛋白并列,成为理解人类健康与疾病的高关注蛋白靶点。

研究设计与样本

  • 本文为综述,讨论多种转运体及其对在体PET放射性示踪剂开发与应用的重要性。

主要发现

  • 转运体可作为主要靶点,通过开发特异性高亲和力放射性配体实现,例如用于脑神经末梢成像的多种神经膜神经递质或囊泡转运体高亲和力放射性配体。
  • 放射性示踪剂的目标可能是通过使用放射性标记底物研究转运体功能,例如应用3-O-[11C]甲基葡萄糖测量通过血脑屏障的葡萄糖转运速率。
  • 在许多情况下,转运体是放射性示踪剂分布所必需的,但所靶向的生化过程可能无关,例如使用2-脱氧-2-[18F]FDG成像葡萄糖代谢时,放射性示踪剂初始穿过细胞膜需要特定葡萄糖转运体的作用。
  • 存在如p-糖蛋白等转运体,其功能是将小分子从组织中排出,可有效对抗放射性示踪剂的成功摄取。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the field of PET has expanded and an ever-increasing number and variety of compounds have been radiolabeled as potential in vivo tracers of biochemistry, transporters have become important primary targets or facilitators of radiotracer uptake and distribution. A transporter can be the primary target through the development of a specific high-affinity radioligand: examples are the multiple high-affinity radioligands for the neuronal membrane neurotransmitter or vesicular transporters, used to image nerve terminals in the brain. The goal of a radiotracer might be to study the function of a transporter through the use of a radiolabeled substrate, such as the application of 3-O-[11C]methyl]glucose to measure rates of glucose transport through the blood-brain barrier. In many cases, transporters are required for radiotracer distributions, but the targeted biochemistries might be unrelated: an example is the use of 2-deoxy-2-[18F]FDG for imaging glucose metabolism, where initial passage of the radiotracer through cell membranes requires the action of specific glucose transporters. Finally, there are transporters such as p-glycoprotein that function to extrude small molecules from tissues, and can effectively work against successful uptake of radiotracers. The diversity of structures and functions of transporters, their importance in human health and disease, and their role in therapeutic drug disposition suggest that in vivo imaging of transporter location and function will continue to be a point of emphasis in PET radiopharmaceutical development. In this review, the variety of transporters and their importance for in vivo PET radiotracer development and application are discussed. Transporters have thus joined the other major protein targets such as G-protein coupled receptors, ligand-gated ion channels, enzymes, and aggregated proteins as of high interest for understanding human health and disease.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kilbourn MR. Small Molecule PET Tracers for Transporter Imaging. Semin Nucl Med. 2017. PMID: 28826525. doi:10.1053/j.semnuclmed.2017.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。